Nedira Salzman-Frenkel.
Corporate Officer/Principal bij NEUROSENSE THERAPEUTICS LTD.
Profiel
Nedira Salzman-Frenkel is currently the Vice President-Business Development at Neurosense Therapeutics Ltd.
Previously, she served as the Chief Executive Officer at Radikal Therapeutics, Inc. from 2017 to 2021.
Ms. Salzman-Frenkel holds a graduate degree from The Hebrew University of Jerusalem, an undergraduate degree from Ben-Gurion University of the Negev, and an MBA from Recanati School of Business Administration.
Actieve functies van Nedira Salzman-Frenkel.
| Bedrijven | Functie | Begin |
|---|---|---|
| NEUROSENSE THERAPEUTICS LTD. | Corporate Officer/Principal | 01-03-2022 |
Eerdere bekende functies van Nedira Salzman-Frenkel.
| Bedrijven | Functie | Einde |
|---|---|---|
Radikal Therapeutics, Inc.
 Radikal Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Radikal Therapeutics, Inc. develops transformative pharmaceuticals of bifunctional edox-based small molecules. The company was founded by Andrew L. Salzman and is headquartered in West Tisbury, MA. | Algemeen Directeur | 01-10-2021 |
Opleiding van Nedira Salzman-Frenkel.
| Ben-Gurion University of the Negev | Undergraduate Degree |
| The Hebrew University of Jerusalem | Graduate Degree |
| Recanati School of Business Administration | Masters Business Admin |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| NEUROSENSE THERAPEUTICS LTD. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Radikal Therapeutics, Inc.
Radikal Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Radikal Therapeutics, Inc. develops transformative pharmaceuticals of bifunctional edox-based small molecules. The company was founded by Andrew L. Salzman and is headquartered in West Tisbury, MA. | Commercial Services |
